Evaluating Whole-Body MRI Screening on Its Own Merits: A Commentary

This commentary is a direct response to the JAMA Viewpoint by Davenport and Reeder (2026) regarding elective whole-body MRI (WB-MRI) screening. While we agree on the necessity of rigorous patient consent and structured follow-up, the original piece contains a fundamental methodological limitation: it relies on historical data from failed, single-organ screening programs to extrapolate the risk-benefit profile of modern, multi-system screening technologies. We offer a critical, data-driven counter-weight to these theoretical arguments, introducing specific epidemiological data utilizing a Bayesian framework to explain why a multi-system evaluation behaves differently from single-organ screening. Ultimately, we challenge the medical community to look forward and develop new evidence-based evaluation frameworks tailored to emerging preventive imaging modalities, ensuring that scientific coverage of this rapidly evolving field remains balanced and grounded in the available empirical literature regarding actual clinical yield and long-term psychological outcomes.